© Reuters. AstraZeneca vaccine emerges in Canada
(Reuters) – Canada reported on Saturday a second case of a rare blood clot with low platelets after getting vaccinated with AstraZeneca’s COVID-19 vaccine (NASDAQ 🙂 for a week, while they were said they still recommend the vaccine.
Health Canada said in a statement that the person who had experienced the bizarre event has received treatment and is recovering, adding that the person lives in the province of Alberta.
Based on the available evidence, Canada still believes that the benefits of the AstraZeneca vaccine outweigh the potential risks, the statement said.
Health Canada “will continue to closely monitor the use of all COVID-19 vaccines and test and evaluate any new safety concerns,” the statement said.
Canada reported a vaccine-related first blood clot on Tuesday and a day later, after review, health authorities said it would not restrict use of the AstraZeneca vaccine.
A separate advisory board recommended Canada stop giving vaccines to people under 55 years of age. That committee is in the process of considering its advice.
Canada has stepped up its vaccination campaign, but still has a smaller immunization rate than dozens of other countries, including the United States and Great Britain.
Amid a skyrocketing third wave of infections, Ontario, Canada’s most populous province, announced new public health restrictions on Friday, including the closure of provincial borders to tourists domestic tourists.
Fusion Media or anyone associated with Fusion Media will not be liable in any way for loss or damage resulting from dependence on information including data, quotes, charts and buy / sell signals contained in the this site. Please be fully informed about the risks and costs associated with trading the financial markets, which is one of the riskiest investments possible.